| Literature DB >> 34948733 |
Silas Gabriel de Oliveira-Nunes1, Alex Castro1,2, Amanda Veiga Sardeli1, Claudia Regina Cavaglieri1, Mara Patricia Traina Chacon-Mikahil1.
Abstract
Lack of time is seen as a barrier to maintaining a physically active lifestyle. In this sense, interval training has been suggested as a time-efficient strategy for improving health, mainly due to its potential to increase cardiorespiratory fitness. Currently, the most discussed interval training protocols in the literature are the high-intensity interval training (HIIT) and the sprint interval training (SIT). Objective: We investigated, through a systematic review and meta-analysis, which interval training protocol, HIIT or SIT, promotes greater gain in cardiorespiratory fitness (V˙O2max/peak). The studies were selected from the PubMed (MEDLINE), Scopus and Web of Science databases. From these searches, a screening was carried out, selecting studies that compared the effects of HIIT and SIT protocols on V˙O2max/peak. A total of 19 studies were included in the final analysis. Due to the homogeneity between studies (I2 = 0%), fixed-effects analyses were performed. There was no significant difference in the V˙O2max/peak gains between HIIT and SIT for the standardized mean difference (SMD = 0.150; 95% CI = -0.038 to 0.338; p = 0.119), including studies that presented both measurements in mL·kg-1·min-1 and l·min-1; and raw mean differences (RMD = 0.921 mL·kg-1·min-1; 95% CI = -0.185 to 2.028; p = 0.103) were calculated only with data presented in mL·kg-1·min-1. We conclude that the literature generates very consistent data to confirm that HIIT and SIT protocols promote similar gains in cardiorespiratory fitness. Thus, for this purpose, the choice of the protocol can be made for convenience.Entities:
Keywords: HIIT; HIIT vs. SIT; SIT; V˙O2max; interval training
Mesh:
Year: 2021 PMID: 34948733 PMCID: PMC8700995 DOI: 10.3390/ijerph182413120
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
TESTEX Scale.
| Study | Eligibility | Randomization | Allocation | Groups | Blinding of | Assessed | Intention-to-Treat | Between-Group | Variability | Activity | Relative Exercise | Exercise Volume | Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astorino et al., 2017 | 1 | 0 | 0 | 1 | 0 | 2 | 0 | 2 | 1 | 1 | 1 | 0 | 9 |
| Smith-Ryan et al., 2016 | 1 | 1 | 0 | 1 | 0 | 3 | 0 | 2 | 1 | 1 | 1 | 0 | 11 |
| Helgerud et al., 2007 | 1 | 1 | 0 | 1 | 0 | 2 | 0 | 2 | 1 | 0 | 1 | 0 | 9 |
| Bækkerud et al., 2016 | 1 | 1 | 0 | 1 | 0 | 2 | 0 | 2 | 1 | 0 | 1 | 0 | 9 |
| Matsuo et al., 2014 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 2 | 1 | 1 | 1 | 1 | 11 |
| Reljic et al., 2018 | 1 | 1 | 0 | 1 | 0 | 2 | 0 | 2 | 1 | 0 | 1 | 0 | 9 |
| Franch et al., 1998 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 2 | 1 | 1 | 1 | 0 | 8 |
| Hu et al., 2012 | 1 | 1 | 0 | 0 | 0 | 3 | 0 | 2 | 1 | 0 | 1 | 0 | 9 |
| Esfarjani et al., 2007 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 1 | 1 | 1 | 0 | 7 |
| Camacho-Cardenosa et al., 2020 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 7 |
| Sun et al., 2019 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 2 | 1 | 0 | 1 | 0 | 8 |
| Ferley, Hopper and Vukovich, 2016 | 1 | 1 | 0 | 1 | 0 | 2 | 0 | 2 | 1 | 0 | 1 | 0 | 9 |
| Naroa et al., 2013 | 1 | 1 | 0 | 1 | 0 | 3 | 0 | 2 | 1 | 0 | 1 | 0 | 10 |
| Overend et al., 1992 | 1 | 1 | 0 | 1 | 0 | 2 | 0 | 2 | 1 | 0 | 1 | 0 | 9 |
| Firat and Dicle, 2015 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 2 | 1 | 0 | 1 | 0 | 7 |
| Shengyan et al., 2018 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 2 | 1 | 0 | 1 | 0 | 8 |
| Lunt et al., 2014 | 1 | 1 | 0 | 1 | 0 | 3 | 0 | 2 | 1 | 0 | 1 | 0 | 10 |
| Muñoz et al., 2015 | 1 | 0 | 0 | 1 | 0 | 3 | 0 | 2 | 1 | 0 | 1 | 0 | 9 |
| Paul et al., 2002 | 1 | 0 | 0 | 1 | 0 | 3 | 0 | 2 | 1 | 1 | 1 | 0 | 10 |
Figure 1Flowchart of the studies included.
Study characteristics.
| Study | Protocol | Population | Age (years) | BW (kg) | Height (m) | Baseline | Duration (Weeks) | No. of Sessions | Exercise | No of Reps (Start/End) | Reps | Work/Rest Ratio | Δ | Outcomes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smith-Ryan et al., 2016 | HIIT | 32-♀ sedentary | 33 ± 12 | 88.1 ± 15.9 | 1.66 ± 0.53 | 24 ± 7 | 3 | 9 | 5 | 120 s | 2 | 8.83 | O2 Peak was encountered in both groups. | |
| SIT | 90% Power output | 10 | 60 s | 1 | 6.45 | |||||||||
| Helgerud et al., 2007 | HIIT | 40-♀ engaged in endurance training 3x/week | 25 ± 4 | 82 ± 12 | 1.82 ± 0.6 | 55.5 ± 7.4 | 8 | 24 | 90–95% HRmax | 4 | 4 min | 1.3 | 8.96 | Both groups ↑ absolute |
| SIT | 60.5 ± 5.4 | 90–95%Hrmax | 15 | 15 s | 1 | 7.98 | ||||||||
| Ferley; Hopper; Vukovich, 2016 | HIIT | 24: 16-♀ and 8-♂; running experience | 28 ± 7 | 68.4 ± 8.8 | 1.72 ± 0.54 | 50.2 ± 7.2 | 6 | 18 | 68% Vmax | 4–6 | 60% Tmax | NR | 4.58 | |
| SIT | 26 ± 5 | 73.2 ± 12.5 | 1.74 ± 0.84 | 50.2 ± 6.9 | Vmax | 10–14 | 30 s | NR | 4.98 | |||||
| Astorino et al., 2017 | HIIT | 71: 34-♂ and 37-♀ active healthy | 22 ± 5.4 | 69.6 ± 11.4 | 1.74 ± 10 | 39.6 ± 5.6 | 3–4 | 10 | 70–110% PPO | 5–10 | 150 s | 1.3 | 9 | |
| SIT | 68.5 ± 10.3 | 1.72 ± 8 | All out | 8–12 | 60 s | 0.2 | 7.7 | |||||||
| Esfarjani, Laursen, 2007 | HIIT | 17-♂ moderately trained runners | 23 ± 5 | 69.6 ± 11.4 | NR | 39.6 ± 5.6 | 10 | 20 | 60% Tmax | 8 | 60% Tmax | 1 | 9.16 | |
| SIT | 68.5 ± 10.3 | 30 s | 12 | 30 s | 0.11 | 6.19 | ||||||||
| Matsuo et al., 2014 | HIIT | 42-♂ sedentary | 26.5 ± 6.2 | 63 ± 7 | 1.72 ± 5 | 41.9 ± 5.6 | 8 | 40 | 3 min | 3 | 3 min | 1.5 | 21.96 | |
| SIT | 62.4 ± 5.4 | 171 ± 5 | 43.9 ± 6.7 | 30 s | 7 | 30 s | 1.5 | 15.72 | ||||||
| Overend; Cunningham, 1992 | HIIT | 17-♂ active young | 25 ± 3 | 75 ± 9 | 1.77 ± 7 | 3.49 ± 0.26 | 10 | 40 | NR | 3 min | 1.5 | 9.46 | ||
| SIT | 3.15 ± 0.22 | NR | 30 s | 1 | 16.51 | |||||||||
| Firat; Dicle, 2015 | HIT | 20-♂ national level lightweight collegiate rowers | 21 ± 2 | 67 ± 3 | 1.78 ± 6 | 56.6 ± 5.7 | 4 | 8 | 90%PPO | 8 | 2.5 min | 0.833 | 4.91 | |
| SIT | 150% PPO | 10 | 30 s | 0.11 | 5.53 | |||||||||
| Franch et al., 1998 | HIIT | 36-♀ running experience | 30.4 ± 4.8 | NR | NR | 54.8 ± 3.0 | 6 | NR | 3–6 | 4 min | 2 | 6 | ||
| SIT | 30–40 | 15 s | 1 | 3.6 | ||||||||||
| Sun et al., 2019 | HIIT | 42-♀ overweight but healthy | 22 ± 2 | 69 ± 6 | 1.63 ± 5 | 31.5 ± 2.2 | 12 | 36 | 90%PPO | 8–10 | 4 min | 1.33 | 26.67 | |
| SIT | 68 ± 7 | 68 ± 7 | 1.62 ± 3.9 | 31.1 ± 3.6 | 150% PPO | 80 | 6 s | 0.67 | 25.08 | |||||
| Camacho-Cardenosa et al., 2019 | HIIT | 36-♀ running experience | 30.4 ± 4.8 | NR | NR | 25.50 ± 4.93 | 12 | 57 | 90% Wmax | 3–6 | 3 min | 1 | −0.47 | |
| SIT | 25.33 ± 4.62 | all-out | 3–6 | 30 s | 0.16 | 2.88 | ||||||||
| Shengyan et al., 2019 | HIIT | 48-♀ overweight female | 21.5 ± 1.8 | 21.5 ± 1.8 | NR | 31.5 ± 2.2 | 12 | 36 | 80 | 4 min | 0.66 | 8.4 | ||
| SIT | 21.4 ± 1.1 | 31.1 ± 3.6 | 100 rpm with 1.5 kg | NR | 6 s | 1.33 | 7.8 | |||||||
| Reljic; Wittmann; Fischer, 2018 | HIIT | 34: 23-♀ and 11-♂ sedentary | 30 ± 7.1 | 71 ± 14.2 | 1.67 ± 0.11 | 29.3 ± 7.7 | 8 | 16 | 85–95% HRmax | 2 | 4 min | 2 | 16.5 | |
| SIT | 75.6 ± 15.4 | 1.73 ± 0.10 | 85–95% HRmax | 5 | 1 min | 1 | 24.14 | |||||||
| Hu et al., 2021 | HIIT | 66-♀ and ♂ sedentary | 21.2 ± 1.4 | 26 ± 3 | NR | 31.9 ± 6.9 | 12 | 36 | NR | 4 min | 1.3 | 20.5 | ||
| SIT | 34.7 ± 8.7 | 1 kg 100 rpm | 10 | 6 s | 0.6 | 21.5 | ||||||||
| Etxebarria et al., 2014 | HIIT | 14-♂ moderately trained | 33 ± 8 | 78 ± 10 | 1.82 ± 8 | 58.7 ± 8.1 | 3 | 6 | ||||||
| SIT | Near maximal | |||||||||||||
| Baekkerud et al., 2016 | HIIT | 30: 18-♀ and 13-♂ sedentary | 41 ± 9 | 91 ± 14 | 1.73 ± 0,08 | 31.9 ± 6.9 | 6 | 18 | 85–95% HRmax | |||||
| SIT | 34.7 ± 8.7 | 90% HRmax | ||||||||||||
| Lunt et al., 2014 | HIIT | 49: 36♀ and 13-♂ sedentary | 48 ± 6 | NR | NR | 24.2 ± 4.8 | 12 | 36 | 85–95% HRmax | 4 | 4 min | 1.3 | 5.79 | |
| SIT | 50 ± 8; | NR | NR | 25.0 ± 2.8 | All out | 3 | 30 s | 0.125 | 0.8 | |||||
| Paul et al., 2002 | HIIT | 41-♀ high trained athletes | 25 ± 6 | 75 ± 7 | 1.80 ± 5 | 64.5 ± 5.2 | 4 | 8 | Pmax | 8 | 144 s | 0.5 | 5.20 (G1); 7.98 (G2) | |
| SIT | 175% PPO | 12 | 30 s | 0.11 | 3.05 | |||||||||
| Overend; | HIIT | 17-♂ active young | 25 ± 3 | 75 ± 9 | 1.77 ± 7 | 3.49 ± 0.26 | 10 | 40 | NR | 3 min | 1.5 | 9.46 | ||
| SIT | 3.15 ± 0.22 | NR | 30 s | 1 | 16.51 | |||||||||
| Firat; Dicle, 2015 | HIIT | 20-♂ national level lightweight collegiate rowers | 21 ± 2 | 67 ± 3 | 1.78 ± 6 | 56.6 ± 5.7 | 4 | 8 | 90% PPO | 8 | 2.5 min | 0.833 | 4.91 | |
| SIT | 150% PPO | 10 | 30 s | 0.11 | 5.53 | |||||||||
| Fahimeh, 2007 | HIIT | 17-♂ moderately trained runners | 23 ± 5 | 69.6 ± 11.4 | NR | 39.6 ± 5.6 | 10 | 20 | 8 | 60% Tmax | 1 | 9.16 | ||
| SIT | 68.5 ± 10.3 | 12 | 30 s | 0.11 | 6.19 |
Legend: BMI, body mass index; min, minutes; HIIT, high-intensity interval training; SIT, sprint interval training; CON, control; NR, no reported; HR, heart rate; Max, maximal; Vmax, velocity maximum; Pmax, power maximum; PPO, peak power output; v O2max, velocity at the maximal oxygen uptake; O2max, maximal oxygen uptake; RPM, rotations per minute; MAP, maximal aerobic power; VeT, ventilation threshold, CAT, control aerobic training; ♀, women; ♂, men; PAL, physical-activity level; BW, body weight;↑, increase; ↔, no change.
Figure 2Forest plot of standardized mean difference (SMD) between HIIT and SIT; 95% CI, 95% confidence interval; SIT, sprint interval training; HIIT, high-intensity interval training.
Figure 3Forest Plot of raw mean differences (RMD in mL·kg−1·min−1) between HIIT and SIT; 95% CI, 95% confidence interval; SIT, sprint interval training; HIIT, high-intensity interval training.
Figure 4Funnel plot standardized mean difference (SMD) in mean vs. standard error of O2max/peak.
Subgroup analysis.
| Sex | k | SMD | LL | UL | ||
|---|---|---|---|---|---|---|
| Male | 7 | 0.099 | −0.25 | 0.449 | 0.578 | 0.175 |
| Female | 7 | 0.227 | −0.086 | 0.54 | 0.155 | |
| TESTEX score 10 | ||||||
| ≥10 | 4 | 0.172 | −0.229 | 0.573 | 0.401 | 0.401 |
| PAL | ||||||
| Active | 12 | −0.14 | −0.12 | 0.4 | 0.29 | 0.153 |
| Sedentary | 8 | 0.108 | −0.153 | 0.391 | 0.39 | |
| Duration (weeks) | ||||||
| ≥7 | 7 | 0.129 | −0.174 | 0.431 | 0.404 | 0.175 |
| <7 | 13 | 0.131 | −0.109 | 0.371 | 0.284 | |
Legend: k, number of study groups; SMD, standard difference in means (mL·kg·min and L·min); p-value, p-value for significance (p < 0.05) between subgroups; p-diff, p-value for significance (p < 0.05) between categories of subgroups; LL, low limit of 95% confidence interval; UL, upper limit of 95% confidence interval; PAL, physical-activity level.